See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"Science is not only compatible with spirituality; it is a profound source of spirituality."
- Carl Sagan
Quick Explanation
Copied
Concise scientific appraisal — Rueda‑Carrasco, J.
Summary: small publication record (3–12 works depending on identity), low citations (4–8), low h‑index (1–2); work appears domain‑diverse (medicine, traditional medicine, cardiology) with several regional/journal outputs and limited visibility — see OpenAlex and journal records below for raw metrics and paper links.
Key sources:
Long Explanation
Author Review — Rueda‑Carrasco, J.
What I evaluated
Bibliometrics: publications, citations, h‑index from your supplied author and OpenAlex extracts.
Topical breadth and venue type (journal titles, languages, OA status when available).
Evidence strength: sample size of outputs, citation visibility, presence/absence of DOIs and indexing.
Raw evidence (selected)
Key papers flagged in the input: two 2013 articles on Jatropha curcas in Revista cubana de plantas medicinales (links below), a heart‑failure/diet paper, and a randomized trial title on Vitamin D3 + calcium (titles supplied). OpenAlex entries list additional cardiology reviews (2020–2021) and some humanities outputs for one author identity.
Regional/clinical relevance: several outputs in regional journals and clinical reviews indicate engagement with local clinical practice and therapies.
Critical appraisal — limitations & blindspots
Low bibliometric footprint: total citations and h‑index are low (4–8 citations; h‑index 1–2 depending on identity), which limits demonstrated impact and community adoption of findings.
Venue visibility: many listed works are regional journals (Revista cubana de plantas medicinales, Peruvian cardiology journals). These often lack DOIs and broad indexing, reducing discoverability and reproducibility audits.
Incomplete metadata: multiple items lack DOIs, open access full texts, or standard indexing; this raises friction for independent verification and meta‑analysis inclusion.
Heterogeneous topics: publications span medicine, traditional medicine, cardiology, and even humanities — breadth is fine, but narrow, deep expertise in a single, high‑impact research program is not yet evident.
Possible author disambiguation: OpenAlex shows at least two distinct persons matching the name; conflation risks inaccurate metrics if not disambiguated by ORCID or institutional affiliation.
Practical consequences for scientific strength
Given the small publication/citation counts, regional venue focus, and metadata gaps, the current objective evidence supports classifying the author as an early‑career or regionally focused researcher with limited international citation impact to date; scientific claims should be weighted accordingly and verified by direct review of full texts (experiments, sample sizes, methods, blinding, statistical analysis) before using results in broader evidence syntheses.
Peer‑reviewed publications in internationally indexed journals (with DOIs) and replication/confirmation by independent groups.
Higher citation counts and inclusion in systematic reviews/meta‑analyses.
Useful links & raw records
OpenAlex author summary (top match):
Bottom line (visual first)
Interpretation: numerical footprint is small; treat outputs as preliminary/regionally focused evidence pending further verification.
Recommended next steps for verification
Obtain full texts of the named papers (two 2013 Jatropha papers and the randomized trial) and evaluate methods: sample sizes, controls, randomization/blinding, statistical methods, pre‑registration, and conflicts of interest.
Disambiguate author identity via ORCID or institutional email; confirm which works belong to the same researcher.
Search Scopus/WoS/Google Scholar for alternate citation counts and DOIs; update metrics accordingly.
Evidence citations used in this review
Feedback:
Updated: March 17, 2026
BGPT Author Review
Scientific Quality
30%
Low citation impact and small, regionally‑published output limit demonstrated scientific influence; evidence indicates active empirical work but not yet mature or widely validated — suggests early‑career/regional researcher rather than field leader.
Communication Quality
50%
Titles and abstracts (where available) are informative and domain‑appropriate, but many outputs are in regional journals and sometimes lack English abstracts/DOIs, reducing accessibility and clarity for international audiences.
Author Novelty
40%
Work on Jatropha alkaloids and clinical topics is within existing research lines (phytopharmacology, cardiology); not obviously transformative or novel at a global scale based on available records, though regional niches may contain useful local insights.
Scientific Rigor
30%
Unable to assess experimental rigor fully because supplied records lack detailed methods/statistics/DOIs for easy verification; regional journal publications can be rigorous, but current metadata and citation footprint do not yet demonstrate reproducible, high‑rigor outputs.
Script is extracting bibliometric metrics (works, citations, h-index) from OpenAlex/CSV and plotting timelines to quantify author impact and disambiguation gaps.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
That the author already has internationally influential work — falsified by low citations and small h‑index in multiple databases.
That disparate topics imply lack of competence — unclear; multidisciplinary outputs can be legitimate but require per‑paper methodological audit.
Quick Explanation
Long Explanation
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
